LD-2 disclosure · 3rd Quarter - Termination
PARKINSON'S ACTION NETWORK
Coverage · No income or expenses were reported on this filing.
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Medical/Disease Research/Clinical Labs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
H.R. 2595/S. 425, "The National Neurological Diseases Surveillance System Act," all sections; H.R. 3070/S. 3295, "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); H.R. 5856 "Department of Defense Appropriations," all sections relating to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 1546/S. 829, "The Medicare Access to Rehabilitation Services Act of 2011," all sections; P.L. 111-148, "Patient Protection and Affordable Care Act," all sections relating to state exchanges and Essential Health Benefits; P.L. 112-25, "Budget Control Act of 2011," all sections relating to sequestration; and proposed legislation relating to the use of telemedicine under Medicare and other Federal health care programs.
LobbyistsCATHERINE PUGH · ms REBECCA W O'CONNOR · JENNIFER SHERIDAN PALUTE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)